AI
Saturday, February 11, 2023 7:08:27 PM
Here is the picture from the combo trial which from one perspective corroborated that the DCVax-L trial is a huge success.
Using pd-1 inhibitors first and DCVax-L later yields significantly more poor results than the case when the administration order was reversed, which clearly show that first DCVax-L can cause massive t-cell infiltration into the tumor in brain because dendritic cell instructions are well received, and second t-cells have to exist in the tumor tissue in order for pd-1 inhibitors to work.
Using pd-1 inhibitors first and DCVax-L later yields significantly more poor results than the case when the administration order was reversed, which clearly show that first DCVax-L can cause massive t-cell infiltration into the tumor in brain because dendritic cell instructions are well received, and second t-cells have to exist in the tumor tissue in order for pd-1 inhibitors to work.
